A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate. Sanchez-Felipe L, Vercruysse T, Sharma S, Ma J, et al. Nature 2020 Dec 1. pii: 10.1038/s41586-020-3035.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sanchez-Felipe L, Vercruysse T, Sharma S, Ma J, et al. A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate. Nature 2020 Dec 1. pii: 10.1038/s41586-020-3035.
PMID: 33260195